Role of obesity in otitis media in children

Sameer Ahmed1, Ellis Arjmand, Douglas Sidell

  • 1Department of Head and Neck Surgery, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, USA.

Insights

Childhood obesity is linked to increased risk of otitis media, a common ear infection. This review explores the connection, its implications for healthcare, and potential causes.

Area of Science:

  • Pediatric Health
  • Otolaryngology
  • Public Health

Background:

  • The childhood obesity epidemic presents significant health challenges.
  • Obesity is associated with numerous comorbidities, including hypertension and diabetes.
  • Emerging research highlights a connection between obesity and otologic conditions, particularly otitis media.

Purpose of the Study:

  • To review the current understanding of the relationship between otitis media and obesity in children.
  • To discuss the healthcare implications of this association.
  • To explore contributing factors and potential pathophysiologic mechanisms.

Main Methods:

  • Literature review of epidemiological and clinical studies.
  • Analysis of research investigating the link between pediatric obesity and otitis media.
  • Synthesis of findings on associated factors and proposed mechanisms.

Main Results:

  • Epidemiological studies, controlling for socioeconomic factors, support an association between childhood obesity and otitis media.
  • Research indicates otitis media is a significant focus in understanding obesity's impact on otologic health.
  • Identifiable factors and potential pathophysiologic pathways are being explored.

Conclusions:

  • A complex, multifactorial relationship exists between childhood obesity and otitis media.
  • Understanding this link is crucial for effective healthcare management and prevention strategies.
  • Further research into pathophysiologic mechanisms is warranted.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
364
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
434
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
321
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
54
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
3.8K